48 results on '"Wright, Jason Dennis"'
Search Results
2. Factors associated with delays in receipt of neoadjuvant chemotherapy in patients with operable breast cancer.
3. Delays in receipt of neoadjuvant chemotherapy compared to upfront surgery in patients with operable breast cancer.
4. Impact of delays in neoadjuvant chemotherapy initiation on pathologic complete response among patients with HER2-positive or triple negative breast cancer.
5. Optimizing the implementation of systematic financial screening.
6. Efficacy of a password-protected, pill-dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery.
7. Identifying DNA methylation signatures in high-grade serous ovarian cancer: Results vary by control tissue type.
8. Incorporating systematic financial screening into the electronic health record.
9. Efficacy of a password-protected pill-dispensing device to enhance disposal of unused opioids after cancer surgery.
10. Impact of a hospital specialty pharmacy in partnership with a free-standing care coordination organization on time to delivery and receipt of oral anticancer drugs.
11. Integration of germline multigene panel testing into breast and gynecologic oncology clinics.
12. Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs.
13. Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).
14. Factors associated with failure to receive oral anticancer drugs.
15. Patient factors associated with time to medication receipt of oral anti-cancer drugs.
16. Inequity in location and quality of death of advanced cancer patients by immigrant status.
17. The COVID-19 pandemic impact on breast cancer care delivery at an academic center in New York City.
18. Opioid prescribing practices in adolescent and young adults with sarcomas.
19. Uptake of targeted therapy in clinical practice among US patients with ovarian cancer.
20. Use of nonclinical staff to coordinate oral anticancer drug prescriptions.
21. Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials.
22. Factors associated with over and underuse of response evaluation in elderly myeloma patients.
23. Delay in receipt of newly prescribed oral anticancer drugs.
24. Quality of care and survival of women with uterine cancer by Hispanic origin: An NCDB analysis.
25. Factors associated with non-adherence to lenalidomide in patients with multiple myeloma.
26. Factors associated with follow-up physician visits among women with early stage breast cancer.
27. Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors
28. Factors associated with neurokinin-1 receptor antagonist use among commercially insured cancer patients receiving highly emetogenic chemotherapy.
29. Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants in SWOG clinical trials.
30. Diffusion of abiraterone use in prostate cancer patients.
31. Understanding efficiency of chemotherapy delivery for planned chemotherapy admission at Columbia University Medical Center.
32. Utilization and effectiveness of extended-duration thromboprophylaxis after high-risk abdominopelvic cancer surgery.
33. Tolerability and toxicity profiles of antibody-drug conjugates for the treatment of malignant neoplasms: A meta-analysis of randomized clinical trials.
34. Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer.
35. Racial and ethnic disparities in quality of diagnostic evaluation for uterine cancer among Medicare patients.
36. Molecular profiling of triple-negative endometrial cancers (TNEC) and triple-negative breast cancers (TNBC) to reveal unique expression profiles.
37. The influence of hospital and surgeon factors on the prevalence of axillary evaluation in ductal carcinoma in situ.
38. Sexual and marital dysfunction in women with gynecologic cancer: A multi-institutional, cross-sectional trial.
39. Serum tumor marker utilization in patients with advanced solid tumors.
40. Long-term consequences of intermittent and continuous androgen deprivation in older patients with metastatic prostate cancer.
41. Trends and safety of image-guided percutaneous pleural biopsies in cancer patients.
42. Relationship between surgical oncologic outcomes and publically reported hospital quality measures.
43. Influence of extent of lymphadenectomy on survival for localized non-small cell lung cancer.
44. Prolonged radiation duration in women with cervical cancer: A population-based analysis of associated factors and impact on survival.
45. Off-label and compendia use of chemotherapy in patients with metastatic cancer.
46. Use of high-intensity surveillance in patients following a diagnosis of stage I-II non-small cell lung cancer.
47. Influence of hospital characteristics on immediate breast reconstruction following mastectomy.
48. Implementation of EHR medication-adherence screening tool in breast cancer clinic.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.